US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Dividend Growth Split Corporation (PK) (DDWWF) 銘柄情報

Dividend Growth Split Corporation (PK) (DDWWF)

6.14

0.00

(0.00%)

終了 7月11日 5:00AM

Dividend Growth Split Corporation (PK) (DDWWF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

6.14

( - )

買値

5.80

売値

6.45

出来高

-

平均取引量 (3 か月)

US$ 129,509

財務取引量

-

0.00 日の範囲 0.00

5.139 52 週間の範囲 6.3928

時価総額

企業価値

78.283M

前日終値

6.14

始値

-

時刻

最終取引時間

VWAP

-

歳入

151.54M

純利益

115.91M

発行済株式数

58,832,206

浮動株比率 (%)

-

機関投資家保有比率 (%)

-

配当利回り

1.2 (15.38%)

PER

3.72

株価売上高倍率 (PSR)

3.36

1 株当たり利益 (EPS)

2.33

ベータ

1.64

Dividend Growth Split Corp. is a closed-ended equity mutual fund launched and managed by Brompton Funds Limited. The fund invests in the public equity markets of Canada. It invests in stocks of companies operating across diversified sectors. The fund primarily invests in stocks of large-cap companie... Dividend Growth Split Corp. is a closed-ended equity mutual fund launched and managed by Brompton Funds Limited. The fund invests in the public equity markets of Canada. It invests in stocks of companies operating across diversified sectors. The fund primarily invests in stocks of large-cap companies. It benchmarks the performance of its portfolio against the S&P/TSX Composite Index. Dividend Growth Split Corp. was formed on September 25, 2007 and is domiciled in Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.bromptongroup.com

本社

Toronto, Canada

設立

2026

Dividend Growth Split Corporation (PK) is listed in the sector of the その他OTC with ticker DDWWF. The last closing price for Dividend Growth Split (PK) was US$6.14. Over the last year, Dividend Growth Split (PK) shares have traded in a share price range of US$ 5.139 to US$ 6.3928.

Dividend Growth Split (PK) currently has 58,832,206 shares in issue. The market capitalisation of Dividend Growth Split (PK) is US$361.23 million. Dividend Growth Split (PK) has a price to earnings ratio (PE ratio) of 3.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	6.14	6.25	6.14	225	6.14	CS
4	-0.06	-0.967741935484	6.2	6.3928	6.13	142	6.17797647	CS
12	0.135	2.2481265612	6.005	6.3928	6.005	392	6.11545442	CS
26	0.38	6.59722222222	5.76	6.3928	5.25	521	5.85119624	CS
52	0.908	17.3547400612	5.232	6.3928	5.139	934	5.54561849	CS
156	2.2444	57.6137180409	3.8956	6.3928	2.86	1469	4.69979863	CS
260	0.79	14.7663551402	5.35	6.3928	2.86	1342	4.72251656	CS

DDWWF - Frequently Asked Questions (FAQ)

What is the current Dividend Growth Split Corporation (PK) share price?

The current share price of Dividend Growth Split Corporation (PK) is US$ 6.14

How many Dividend Growth Split Corporation (PK) shares are in issue?

Dividend Growth Split Corporation (PK) has 58,832,206 shares in issue

What is the market cap of Dividend Growth Split Corporation (PK)?

The market capitalisation of Dividend Growth Split Corporation (PK) is USD 361.23M

What is the 1 year trading range for Dividend Growth Split Corporation (PK) share price?

Dividend Growth Split Corporation (PK) has traded in the range of US$ 5.139 to US$ 6.3928 during the past year

What is the PE ratio of Dividend Growth Split Corporation (PK)?

The price to earnings ratio of Dividend Growth Split Corporation (PK) is 3.72

What is the cash to sales ratio of Dividend Growth Split Corporation (PK)?

The cash to sales ratio of Dividend Growth Split Corporation (PK) is 3.36

What is the registered address of Dividend Growth Split Corporation (PK)?

The registered address for Dividend Growth Split Corporation (PK) is Bay Wellington Tower, Toronto, Ontario, M5J 2T3

What is the Dividend Growth Split Corporation (PK) website address?

The website address for Dividend Growth Split Corporation (PK) is www.bromptongroup.com/funds/fund/dgs/overview

DTGoody

DTGoody 3分前

They're going to reverse merge with a Medical Courier Driver from PA to Deliver Anti-Depressants to the ENCC Shareholders who sold their shares right before a massive reverse merger happened! LOL :))

chereb19

chereb19 7分前

This post is a good reminder that confidence and accuracy aren't the same thing. You predicted the FDA wouldn't "give the green light." The FDA subsequently approved the IDE to begin the human feasibility study. It's perfectly reasonable to remain skeptical, but it's also reasonable to acknowledge w

Wallstreeter$$$

Wallstreeter$$$ 27分前

Typical lazy DD Norman cuz u wouldve seen I later said I would hold a core position in Vivos longer term. Btw numbnuts I've been swing trading this from day one, sometimes taking small profits but reinvesting most of it in new stock. Heck i've been increasing my position without spending one red cen

searay2701

searay2701 43分前

I suggest that folks check BRC Laboratory com. A test has been completed on Insultex but it shows no completion date, could this one with no date on it be from an earlier testing than the one we are currently waiting for?

PickStocks

PickStocks 1時間前

Bill becomes law?

north40000

north40000 1時間前

“Cost-saving legislation in healthcare passed by German parliament didn’t help matters either.

murrayhill

murrayhill 1時間前

O'Jays - Backstabber
https://www.youtube.com/watch?v=RmXRQ3vfzcA

flipper44

flipper44 2時間前

Hi Baxers, I just don’t buy that a proposed refusal occurred followed by an appeal.

Perhaps this is one of those rare moments opposite forces align to try and make NWBO spill the beans.

Regardless, the way the system works, according to MHRA, is that CTBVEAG does not ma

janice shell

janice shell 2時間前

You know all the fuss that's being made about the tacky "Freedom Fuel" gas stations that have popped up in Southeast Pennsylvania and part of New Jersey...

All over the news for several days now. It's a mystery!! Who owns them? Some Trump buddy? Very likely, but oddly enough, nobody

shajandr

shajandr 2時間前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 2時間前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Kool Aid Man

Kool Aid Man 2時間前

Q:--"Why would a Royal Qatari Sheikh worth multi-millions need an infamous, maxed out, toxic ticker littered with legal landmines in order to 'self fund' mining and drilling on at least 3 continents then split his profits with decades of old HIRU bag holders???"

A: He doesn't

shajandr

shajandr 2時間前

Roofie the prison janitor.

jjjjjjjj

jjjjjjjj 2時間前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN!
Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. DAMNED IF IT GOES DOWN! Is today Mond

Kool Aid Man

Kool Aid Man 2時間前

Has the bank said "no money was lost"? Then why are they suing?

rosemountbomber

rosemountbomber 3時間前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

Genz2 3時間前

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 3時間前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

smoki 3時間前

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

Dividend Growth Split (PK)

TCW Transform Systems ETF

Morgan Creek Exos Active...

iShares MSCI World Small...

DJ Commodity Index Soybe...

Vanguard Value ETF

Biora Therapeutics

Jpmorgan Chase Financial...

Advance TC (EM)

Rocci0786%14dec46 Rocci0...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。